Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qigui Yishen Recipe is a Traditional Chinese Medicine (TCM) compound preparation primarily investigated for its potential to delay the progression of chronic kidney disease (CKD), particularly renal fibrosis. It is recognized for its traditional functions of invigorating the kidney and spleen, enhancing qi, and stimulating blood circulation. Network pharmacology studies indicate that its therapeutic effects are mediated by active ingredients such as sitosterol, stigmasterol, mannitol, and quercetin. These components are believed to contribute to anti-inflammatory and anti-fibrotic actions, thereby reducing inflammation-induced kidney damage and preventing renal fibrosis. The preparation has been associated with a national patent (Patent No. ZL201310069692.0).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qigui Yishen Recipe.